Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis.
Naveen C HegdeAnkit KumarAmol N PatilSamiksha BhattacharjeeNanda GamadKripa Shanker KasudhanVivek KumarPankaj MalhotraPublished in: Acta diabetologica (2023)
The renoprotective efficacy of SGLT2i is independent of the incremental doses suggesting lower doses may suffice for renal outcomes.